Voluntary announcement-business update on the grant of China invention patents related to osemitamab (TST001) and its companion diagnostic antibody
Filed with HKEX · Stock code 6628 · · 2 pages · English
Summary by 6ix AI
Transcenta Holding Limited has announced the grant of a China invention patent related to osemitamab and its companion diagnostic antibody, which is a significant development for the company. This update highlights the company's efforts in strengthening its intellectual property position and advancing its precision medicine strategy.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Transcenta Holding Limited on 6ix
Earlier from Transcenta
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Cancellation and grant of award pursuant to the share incentive scheme
- Notification letter and request form to non-registered holders
- Notification letter and reply form to registered holders
- 2026 Interim report
Later from Transcenta
All Transcenta news releasesFollow Transcenta into a list and get an email when it puts out news.
Follow Transcenta